NCT05295433: An ongoing trial by ModernaTX, Inc.
This trial is ongoing. It must report results 8 years, 10 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05295433 |
|---|---|
| Title | A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705 |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 8, 2022 |
| Completion date | April 2, 2034 |
| Required reporting date | April 2, 2035, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 22, 2026 |
| Days late | None |